Multi-frequency impedance monitoring system

• US 9,642,558 B2
• Filed: 06/03/2014
• Issued: 05/09/2017
• Est. Priority Date: 04/30/2008
• Status: Active Grant

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: Hettrick, Douglas A, Sarkar, Shantanu, Zielinski, Todd M
• Primary Examiner(s): HINDENBURG, MAX F
• Application Number:
  US14/294,877
• Publication Number:
  US 20140288455A1
• Time in Patent Office: 1,071 Days
• CPC Class Codes: A61B 5/053 Measuring electrical impedance or conductance of a portion of the body
• CPC Class Codes: A61B 5/0538 invasively, e.g. using a catheter
• CPC Class Codes: A61B 5/0809 by impedance pneumography
• CPC Class Codes: A61B 5/4869 Determining body composition
• CPC Class Codes: A61B 5/686 Permanently implanted devices, e.g. pacemakers, other stimulators, biochips A61B5/6861 takes precedence
• CPC Class Codes: A61B 5/7257 using Fourier transforms
• CPC Class Codes: A61N 1/36521 the parameter being derived from measurement of an electrical impedance

Abstract

A system and method is provided to measure intrathoracic complex impedance and to identify and indicate disease conditions based on the impedance measurements. Multiple impedance vectors may be taken into account, and an optimal vector may be selected to provide the most useful impedance measurement for the identification and indication of disease conditions.

Claims

1. A system for measuring intrathoracic impedance across a plurality of selected tissue segments, comprising:

at least one lead carrying a plurality of electrodes, the electrodes being positioned so that selected pairs of electrodes span selected ones of the plurality of selected tissue segments;

impedance measurement circuitry for measuring an impedance between the selected pairs of electrodes; and

processing circuitry for evaluating the measured impedance between at least one of the selected pairs of electrodes to determine whether the tissue segment is in a diseased condition, and for providing an indicator of disease based on the determination of whether the tissue segment is in a diseased condition.

2. A system according to claim 1, wherein the at least one lead is connected to an implantable medical device (IMD) that houses the impedance measurement circuitry and the processing circuitry.

3. A system according to claim 2, wherein the IMD comprises at least one electrode.

4. A system according to claim 3, wherein at least a portion of the at least one lead is positioned over a left ventricle via a cardiac vein or epicardially, and the electrodes carried by the at least one lead are positioned in at least one of the cardiac vein over the left ventricle, epicardially over the left ventricle, a right atrium, and a subclavian vein.

5. A system according to claim 1, wherein at least a portion of the at least one lead is positioned in a right ventricle and the electrodes carried by the at least one lead are positioned in at least one of the right ventricle, a right atrium, a superior vena cava and a subclavian vein.

6. A system according to claim 1, wherein at least a portion of the at least one lead is positioned over a left ventricle via a cardiac vein, and the electrodes carried by the at least one lead are positioned in at least one of the cardiac vein over the left ventricle, a right atrium, and a subclavian vein.

7. A system according to claim 1, wherein at least a portion of the at least one lead is positioned in an inferior vena cava, and the electrodes carried by the at least one lead are positioned in at least one of the inferior vena cava, a right atrium, a superior vena cava and a subclavian vein.

8. A system for measuring intrathoracic impedance across a plurality of selected tissue segments, comprising:

at least one lead carrying a plurality of electrodes, the electrodes being positioned so that selected pairs of electrodes span selected ones of the plurality of selected tissue segments;

impedance measurement circuitry for measuring an impedance between the selected pairs of electrodes; and

processing circuitry for evaluating the measured impedance between at least one of the selected pairs of electrodes to determine whether the tissue segment is in a diseased condition, and for providing an indicator of disease based on the determination of whether the tissue segment is in a diseased condition;

wherein the at least one lead includes a first lead positioned in a left lateral thorax, and electrodes carried by the first lead are positioned in the left lateral thorax.

9. A system according to claim 8, wherein the at least one lead further includes a second lead at least partially positioned in a right ventricle, and electrodes carried by the second lead are positioned in at least one of the right ventricle, a right atrium, a superior vena cava and a subclavian vein.

10. A system according to claim 8, wherein the at least one lead further includes a second lead at least partially positioned over a left ventricle via a cardiac vein, and electrodes carried by the second lead are positioned in at least one of the cardiac vein over the left ventricle, epicardially over the left ventricle, a right atrium, and a subclavian vein.

11. A system for measuring intrathoracic impedance across a plurality of selected tissue segments, comprising:

at least one lead carrying a plurality of electrodes, the electrodes being positioned so that selected pairs of electrodes span selected ones of the plurality of selected tissue segments;

impedance measurement circuitry for measuring an impedance between the selected pairs of electrodes; and

processing circuitry for evaluating the measured impedance between at least one of the selected pairs of electrodes to determine whether the tissue segment is in a diseased condition, and for providing an indicator of disease based on the determination of whether the tissue segment is in a diseased condition;

wherein a pair of the selected pairs of electrodes is selected for measurement of impedance therebetween based on a determination that a ratio between a cardiac component of impedance and a respiratory component of impedance is greatest among the selected pairs of electrodes.

12. A system according to claim 11, wherein the at least one lead is connected to an implantable medical device (IMD) that houses the impedance measurement circuitry and the processing circuitry.

13. A system according to claim 12, wherein the IMD comprises at least one electrode.

14. A system according to claim 13, wherein at least a portion of the at least one lead is positioned over a left ventricle via a cardiac vein or epicardially, and the electrodes carried by the at least one lead are positioned in at least one of the cardiac vein over the left ventricle, epicardially over the left ventricle, a right atrium, and a subclavian vein.

15. A system according to claim 11, wherein at least a portion of the at least one lead is positioned in a right ventricle and the electrodes carried by the at least one lead are positioned in at least one of the right ventricle, a right atrium, a superior vena cava and a subclavian vein.

16. A system according to claim 11, wherein at least a portion of the at least one lead is positioned over a left ventricle via a cardiac vein, and the electrodes carried by the at least one lead are positioned in at least one of the cardiac vein over the left ventricle, a right atrium, and a subclavian vein.

17. A system according to claim 11, wherein at least a portion of the at least one lead is positioned in an inferior vena cava, and the electrodes carried by the at least one lead are positioned in at least one of the inferior vena cava, a right atrium, a superior vena cava and a subclavian vein.